A Prospective, Randomised, Placebo Controlled, Double Blind Trial About Safety and Efficacy of Combined Treatment With Alteplase (rt-PA) and Cerebrolysin in Acute Ischaemic Hemispheric Stroke.

Trial Profile

A Prospective, Randomised, Placebo Controlled, Double Blind Trial About Safety and Efficacy of Combined Treatment With Alteplase (rt-PA) and Cerebrolysin in Acute Ischaemic Hemispheric Stroke.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Feb 2017

At a glance

  • Drugs Alteplase; Brain extract
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms CERE-LYSE-1
  • Most Recent Events

    • 14 Feb 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top